A Controversial Chinese Malaria Strategy in Kenya

A Chinese philanthropist and Chinese researchers have embraced a bold goal: Eliminating malaria from Kenya using mass drug administration.

By giving antimalarials to every Kenyan, New South CEO Zhu Layi and team hope to eliminate Kenya’s human malaria reservoir—leading to huge health benefits. Building on a successful MDA effort in the island nation of Comoros, Zhu Layi is talking with Kenyan officials about a test run with 10,000 people near Mombasa.

MDA is controversial because it risks increasing drug resistance and sparks ethical questions about giving medications to people who don’t have the disease. 

The Atlantic

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top